Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Market indices provide a snapshot of broad performance and risk. This overview outlines why investors rely on them for benchmarking.
28,391 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
A bold new AI model from Z.AI promises high performance without Nvidia chips. This article breaks down what GLM-5.2 m...
Beijing and Hong Kong unveiled a coordinated package to deepen offshore yuan liquidity and gold settlement, signaling...
CryptoQuant urges Strategy to pause BTC purchases amid cash strain and ballooning dividends, signaling a potential sh...
When headlines shout about dream finders homes struggles, investors should look past the noise and examine the fundam...
Ford faces renewed scrutiny as recalls mount and U.S. sales soften, fueling a debate over whether ford should give ba...
As BTC consolidates in 2026, Coinbase, BlackRock and Strategy emerge as the top on-chain holders. This report breaks ...
Many investors worry about a credit squeeze, especially when debt levels rise and lending standards tighten. This gui...
A surge of commentary in crypto circles centers on XRP's function within Ripple's rails, pitting advocates of open fi...
Growth stocks cooled in early 2026, but a trio of ETFs offers a resilient path for long-term investors. This piece br...
A luxury tax on second homes could reshape New York City's budget and housing market. This article weighs the potenti...
Payrolls rose by 115,000 in April, beating forecasts as the unemployment rate held at 4.3%. The report comes as oil-m...